Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 6951-7000 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05743881
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
PHASE1Active, not recruiting
186 participants
Started: Feb 15, 2023 · Completed: Sep 30, 2026
2 conditions1 sponsor58 locations
NCT05720923
Analysis of Muscular Properties in Patients With MFS and EDS
N/AActive, not recruiting
65 participants
Started: Feb 15, 2023 · Completed: Jan 31, 2026
3 conditions2 sponsors1 location
NCT05690386
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
PHASE2Active, not recruiting
48 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor19 locations
NCT03992469
Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
PHASE1Active, not recruiting
7 participants
Started: Feb 15, 2023 · Completed: Feb 2, 2026
1 condition1 sponsor1 location
NCT05742945
Can ILR Reduce the Risk of Arm Lymphedema?
NAActive, not recruiting
240 participants
Started: Feb 14, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06253533
ICVAX as a HIV Therapeutic DNA Vaccine
PHASE1Active, not recruiting
45 participants
Started: Feb 14, 2023 · Completed: Jun 30, 2025
2 conditions3 sponsors1 location
NCT06611852
Efficacy of Combined Interferential Therapy and Electronic Cupping Therapy for Chronic Constipation Management
NAActive, not recruiting
110 participants
Started: Feb 14, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05722015
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
PHASE3Active, not recruiting
377 participants
Started: Feb 14, 2023 · Completed: May 22, 2028
1 condition1 sponsor110 locations
NCT04711109
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
PHASE3Active, not recruiting
300 participants
Started: Feb 14, 2023 · Completed: Dec 31, 2033
6 conditions3 sponsors47 locations
NCT05666310
Muscle Impact of Treating Osteoporosis
PHASE4Active, not recruiting
20 participants
Started: Feb 14, 2023 · Completed: Jul 1, 2026
2 conditions3 sponsors1 location
NCT06651398
A Study to Investigate the Effect of a Meal At 6pm the Day Before the Colonoscopy on the Bowel Cleansing with Plenvu
NAActive, not recruiting
525 participants
Started: Feb 14, 2023 · Completed: Nov 30, 2024
4 conditions2 sponsors1 location
NCT05261828
Efficacy of a Short Multidisciplinary Education and Rehabilitation Program for Patients With Subacute and Chronic Low Back Pain (LBP)
NAActive, not recruiting
100 participants
Started: Feb 14, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05811156
A Biopsychosocial Treatment for Exhaustion Due to Persistent Non-traumatic Stress
N/AActive, not recruiting
26 participants
Started: Feb 14, 2023 · Completed: Jul 31, 2024
2 conditions2 sponsors1 location
NCT05731570
Cognitive Rehabilitation for People With Cognitive Covid19
NAActive, not recruiting
78 participants
Started: Feb 14, 2023 · Completed: Sep 30, 2024
1 condition6 sponsors1 location
NCT05723185
Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational Study
N/AActive, not recruiting
246 participants
Started: Feb 13, 2023 · Completed: Dec 31, 2025
8 conditions3 sponsors1 location
NCT05561751
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
PHASE2Active, not recruiting
40 participants
Started: Feb 13, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor10 locations
NCT05570786
Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment
PHASE2Active, not recruiting
100 participants
Started: Feb 13, 2023 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT05686512
Initial Evaluation of a Stepped Care Model for Treating Mild to Moderate Childhood Anxiety in Primary Care
NAActive, not recruiting
30 participants
Started: Feb 13, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05515406
A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
PHASE1Active, not recruiting
108 participants
Started: Feb 13, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor10 locations
NCT05745246
Firefighters Preventing Cancer Online Training Program
NAActive, not recruiting
179 participants
Started: Feb 13, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05201066
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
PHASE2Active, not recruiting
33 participants
Started: Feb 13, 2023 · Completed: Feb 14, 2028
2 conditions1 sponsor24 locations
NCT05666778
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
PHASE2Active, not recruiting
408 participants
Started: Feb 13, 2023 · Completed: Jul 31, 2027
5 conditions5 sponsors2 locations
NCT05843994
Artificial Intelligence Patient App for RDEB SCCs
N/AActive, not recruiting
20 participants
Started: Feb 13, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06520280
Comparative Study Between Injection Molding and Additive Manufacturing Complete Denture
NAActive, not recruiting
10 participants
Started: Feb 13, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05504720
Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma
PHASE2Active, not recruiting
31 participants
Started: Feb 13, 2023 · Completed: Dec 31, 2027
1 condition3 sponsors13 locations
NCT05685238
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)
PHASE3Active, not recruiting
451 participants
Started: Feb 13, 2023 · Completed: Jun 30, 2028
2 conditions1 sponsor128 locations
NCT05722353
IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®
NAActive, not recruiting
120 participants
Started: Feb 13, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05431699
Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test
NAActive, not recruiting
9,100 participants
Started: Feb 13, 2023 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT05742243
Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
PHASE2Active, not recruiting
62 participants
Started: Feb 13, 2023 · Completed: Feb 13, 2027
2 conditions3 sponsors6 locations
NCT06051422
Correlation of Pelvic Asymmetry and Joint Movement During Gait in Children With Cerebral Palsy
N/AActive, not recruiting
20 participants
Started: Feb 12, 2023 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT06827002
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
PHASE1/PHASE2Active, not recruiting
248 participants
Started: Feb 12, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05317754
Effectiveness of Four Deconstructive Meditative Practices on Well-being and Self-deconstruction
NAActive, not recruiting
240 participants
Started: Feb 11, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06450730
Effectiveness of a Combined mHealth-CBT Psychological Intervention to Improve Psychological Well-Being in Young Patients With T1D
NAActive, not recruiting
122 participants
Started: Feb 11, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05456828
A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration
PHASE1Active, not recruiting
56 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05841680
A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment
NAActive, not recruiting
65 participants
Started: Feb 10, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05732571
Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing
NAActive, not recruiting
40 participants
Started: Feb 10, 2023 · Completed: Jul 30, 2024
2 conditions1 sponsor1 location
NCT05673785
A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)
PHASE2Active, not recruiting
52 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor16 locations
NCT05586061
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer
PHASE2Active, not recruiting
55 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05567692
Subjects With T2D or at Risk of T2D Cohort Follow-up
N/AActive, not recruiting
837 participants
Started: Feb 10, 2023 · Completed: Oct 1, 2032
1 condition2 sponsors1 location
NCT05682378
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies
PHASE3Active, not recruiting
125 participants
Started: Feb 10, 2023 · Completed: Mar 2, 2028
1 condition1 sponsor51 locations
NCT07195760
Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury
N/AActive, not recruiting
600 participants
Started: Feb 10, 2023 · Completed: Jan 31, 2027
4 conditions1 sponsor1 location
NCT04390971
Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia
NAActive, not recruiting
3 participants
Started: Feb 10, 2023 · Completed: Aug 15, 2025
1 condition4 sponsors3 locations
NCT05485753
A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors4 locations
NCT07115576
Single-Session Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: A Prospective Study
NAActive, not recruiting
130 participants
Started: Feb 10, 2023 · Completed: Apr 10, 2026
1 condition2 sponsors1 location
NCT05660642
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
PHASE2Active, not recruiting
64 participants
Started: Feb 10, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT05555862
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
PHASE2Active, not recruiting
17 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2026
6 conditions5 sponsors2 locations
NCT05521867
Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures
NAActive, not recruiting
96 participants
Started: Feb 10, 2023 · Completed: Apr 9, 2026
1 condition1 sponsor1 location
NCT06144515
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
N/AActive, not recruiting
100 participants
Started: Feb 9, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05664971
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
PHASE1/PHASE2Active, not recruiting
119 participants
Started: Feb 9, 2023 · Completed: Nov 17, 2025
1 condition1 sponsor1 location
NCT05546866
Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm
PHASE2Active, not recruiting
51 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2029
1 condition1 sponsor10 locations